Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia, Study 2.
Phase of Trial: Phase III
Latest Information Update: 02 May 2012
At a glance
- Drugs Tolvaptan (Primary)
- Indications Chronic heart failure; Hyponatraemia
- Focus Therapeutic Use
- Acronyms SALT-2
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 02 May 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00201994).
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History